2006
DOI: 10.1080/00313020600817951
|View full text |Cite
|
Sign up to set email alerts
|

The role of cell cycle regulatory proteins in the pathogenesis of melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
111
0
64

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 123 publications
(184 citation statements)
references
References 160 publications
9
111
0
64
Order By: Relevance
“…In agreement with our results, p21 levels are usually low or undetectable in the majority of cutaneous nevi, with greater expression in primary melanomas [8,21,22]. The exact mechanism causing the increased expression of p21 in primary melanomas is unclear, although possible hypotheses include microenvironmental signals, checkpoint adaptation, p21 mutations, altered or inhibited p21 binding to cyclin/cdk complexes and abnormal protein degradation [5]. On the other hand, the expression of p21 is lower in melanoma metastases when compared with the corresponding primary lesions in most studies [20,22].…”
Section: Discussionsupporting
confidence: 87%
See 4 more Smart Citations
“…In agreement with our results, p21 levels are usually low or undetectable in the majority of cutaneous nevi, with greater expression in primary melanomas [8,21,22]. The exact mechanism causing the increased expression of p21 in primary melanomas is unclear, although possible hypotheses include microenvironmental signals, checkpoint adaptation, p21 mutations, altered or inhibited p21 binding to cyclin/cdk complexes and abnormal protein degradation [5]. On the other hand, the expression of p21 is lower in melanoma metastases when compared with the corresponding primary lesions in most studies [20,22].…”
Section: Discussionsupporting
confidence: 87%
“…In agreement with these results, cutaneous nevi have been shown to be uniformly positive for p16 in more than 70% of cells [7,15]. On the other hand, loss of p16 expression has also been demonstrated in almost 50% of primary cutaneous and oral melanomas, similarly to many other cancers, including pancreatic, esophageal, lung, head and neck, breast, bladder, brain and ovarian [1,5,13,14]. Although there is general consensus regarding the loss of p16 expression in cutaneous melanomas, it is suggested that this occurs in later stages of the disease, as it is not altered in melanoma in situ [16].…”
Section: Discussionsupporting
confidence: 69%
See 3 more Smart Citations